5-O-[N-PROPYN-1-YL-2-(METHYLAMINO-N-ETHYLAMINO-N-4-METHYL-QUINOLIN-2-YL)-MORPHOLINO]-2-DEOXY-STREPTAMINE
Compound with spectra: 1 NMR
![5-O-[N-PROPYN-1-YL-2-(METHYLAMINO-N-ETHYLAMINO-N-4-METHYL-QUINOLIN-2-YL)-MORPHOLINO]-2-DEOXY-STREPTAMINE](/api/compound/GA2zXaTecAh.png?ph=true&h=300&w=458 "5-O-[N-PROPYN-1-YL-2-(METHYLAMINO-N-ETHYLAMINO-N-4-METHYL-QUINOLIN-2-YL)-MORPHOLINO]-2-DEOXY-STREPTAMINE")
| SpectraBase Compound ID | GA2zXaTecAh |
|---|---|
| InChI | InChI=1S/C36H54N6O8/c1-9-16-42-20-23(19-37-14-15-38-28-17-22(2)24-12-10-11-13-25(24)39-28)47-29(21-42)48-32-30(43)26(40-33(45)49-35(3,4)5)18-27(31(32)44)41-34(46)50-36(6,7)8/h1,10-13,17,23,26-27,29-32,37,43-44H,14-16,18-21H2,2-8H3,(H,38,39)(H,40,45)(H,41,46)/t23-,26-,27+,29+,30+,31-,32-/m0/s1 |
| InChIKey | AZKMYKJBUBNGLG-HWWSYSQRSA-N |
| Mol Weight | 698.9 g/mol |
| Molecular Formula | C36H54N6O8 |
| Exact Mass | 698.400313 g/mol |
| Enantiomer InChIKey | AZKMYKJBUBNGLG-RTTVZZDBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
2-(3',4'-DI-O-BENZOYL-2'-DEOXY-beta-D-RIBOPYRANOSYL)-4-METHYL-QUINOLINE;beta-ISOMER
2-(4-phenyl-quinolin-2-yl)-[1,2,5]oxadiazepane-5-carboxylic acid t-butyl ester
4-[5-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-3-yl]-2-methylquinoline
(2-{2-[4-(6,7-Dimethoxy-4-trifluoromethyl-quinolin-2-ylamino)-benzoylamino]-acetylamino}-acetylamino)acetic acid
(S)-3-(4,8-Dimethylquinolin-2-yl)-4-isopropyloxazolidin-2-one
WHHWFYMEQBOEGK-YYGZZXRFSA-N
WHHWFYMEQBOEGK-XUJYPJAKSA-N
(2S,3S,4R,5S)-N-(TERT.-BUTOXYCARBONYL)-2-(1',2'-DIHYDROXYETHYL)-3,4-ISOPROPYLIDENE-5-METHYLPYRROLIDINE-3,4-DIOL
Methyl 4,6-O-benzylidene-3-O-tosyl-.alpha.,D-mannopyranoside
METHYL-4,6-O-BENZYLIDENE-3-O-PARA-TOLUENESULFONYL-BETA-D-GALACTOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| 2-Deoxystreptamine Conjugates by Truncation–Derivatization of Neomycin | Pharmaceuticals | 2010 |